Vasculitis Pregnancy Registry
Launched by UNIVERSITY OF PENNSYLVANIA · Oct 29, 2015
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Vasculitis Pregnancy Registry is a study aimed at understanding the experiences of women with various types of vasculitis who are pregnant. Vasculitis refers to a group of diseases that cause inflammation of the blood vessels, which can affect different parts of the body. In this study, researchers want to gather information through online surveys about how each woman's condition affects her pregnancy and what the outcomes of these pregnancies are. This information will help improve care and support for women with vasculitis during pregnancy.
To be eligible for this study, women must be 18 years or older, currently pregnant, and have a diagnosed condition from a specific list of vasculitis diseases. Participants will complete online surveys that ask about their health and pregnancy experiences. The study is open to women who speak English, Spanish, Portuguese, Italian, or Turkish. If you are eligible and choose to participate, your experiences could provide valuable insights for others in similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- 1. Women 18 years of age or older with one of the following diseases may take part in the study:
- • Behçet's disease;
- • Central nervous system (CNS) vasculitis;
- • Cryoglobulinemic vasculitis (Cryoglobulinemia);
- • Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
- • Giant Cell (Temporal) Arteritis (GCA);
- • Granulomatosis with polyangiitis (also called Wegener's);
- • IgA vasculitis (Henoch-Schoenlein purpura);
- • Microscopic polyangiitis (MPA);
- • Polyarteritis nodosa (PAN);
- • Takayasu's arteritis (TAK);
- • Urticarial vasculitis;
- • Other/Suspected Diagnosis.
- • 2. Women must be pregnant (self-report) at the time of enrollment into the registry.
- Exclusion Criteria:
- • 1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
- • 2. Unable to provide consent.
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Megan Clowse, MD, MPH
Study Chair
Duke University
Peter A Merkel, MD, MPH
Study Chair
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials